GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.91
-0.99 (-1.40%)
At close: Aug 5, 2026, 4:00 PM EDT
70.00
+0.09 (0.13%)
After-hours: Aug 5, 2026, 5:36 PM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,300 employees as of December 31, 2025. The number of employees increased by 300 or 30.00% compared to the previous year.
Employees
1,300
Change (1Y)
300
Growth (1Y)
30.00%
Revenue / Employee
$349,558
Profits / Employee
-$81,813
Market Cap
2.08B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,300 | 300 | 30.00% |
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Mar 31, 2021 | 985 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Castle Biosciences | 1,002 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
WGS News
- 1 day ago - GeneDx price target raised to $90 from $75 at Canaccord - TheFly
- 2 days ago - GeneDx Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - GeneDx Holdings Slides: Q2 2026 - Filings
- 2 days ago - GeneDx Holdings Earnings release: Q2 2026 - Filings
- 2 days ago - GeneDx Holdings Quarterly report: Q2 2026 - Filings
- 2 days ago - GeneDx Reports Second Quarter 2026 Financial Results - Business Wire
- 6 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS - PRNewsWire
- 20 days ago - GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026 - Business Wire